Back to search
Thromboangiitis Obliterans (Buerger's Disease)
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Thromboangiitis Obliterans (Buerger's Disease) trials may be worth asking aboutClinical trial pipeline · Data from ClinicalTrials.gov
See which Thromboangiitis Obliterans (Buerger's Disease) trials may be worth asking aboutNorth America
Europe
Asia-Pacific
Rest of World
Trials may have sites in multiple countries. Filtering shows any trial with at least one site in the selected country.
This study is a first-in-human clinical trial of drug ATI-1013, in healthy adult cigarette smokers. The main questions it aims to answer are to learn about the…
The goal of this observational, practice-based feasibility study is to observe the efficacy and safety of intramuscular administration of Stempeucel® in Malaysi…
The main objective is to assess the feasibility of treatment by injecting botulinum toxin A into the hand or foot of patients with signs of critical ischemia se…
The purpose of this expanded access program (EAP) is to provide Selexipag (Uptravi) for the treatment of participant with non-healing wound, buerger's disease.